Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
221
天
Real-world population pharmacokinetic modeling of elexacaftor, tezacaftor, and ivacaftor
作者
AK Kunzelmann; S Naehrig; C Shad; M Breuling; M Goetschke; K Habler; O Sommerburg; J Behr; LM Schatz; J Starp; M Vogeser; M Paal; U Liebchen展开收起
作者单位
Department of Anaesthesiology, LMU University Hospital, LMU Munich, 81377, Munich, Germany; Cystic Fibrosis Center for Adults, Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), 80336, Munich, Germany; Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Germany; Institute of Laboratory Medicine, LMU University Hospital, LMU Munich, 81377, Munich, Germany; Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, Department of Pediatrics, University Hospital Heidelberg, Germany. Member of the German Center for Lung Research (DZL), Germany展开收起
43
天
Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study
作者
Emmanuelle Bardin; Hélène Salvator; Camille Roquencourt; Elodie Lamy; Nicolas Hunzinger; Isabelle Sermet-Gaudelus; Sandra De Miranda; Dominique Grenet; Philippe Devillier; Stanislas Grassin-Delyle展开收起
作者单位
Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Paris, France; Université Paris-Saclay, UVSQ, INSERM, Infection et inflammation (2I), U1173, Département de Biotechnologie de la Santé, Unité Technologies pour la Santé et le Médicament, Montigny le Bretonneux, France; Hôpital Foch, Exhalomics®, Suresnes, France; Hôpital Necker Enfants Malades, Centre de Référence Maladies Rares, Paris, France; Université Paris-Saclay, UVSQ, UFR Simone Veil-Santé, VIM-Suresnes, UMR0892, Suresnes, France; Hôpital Foch, Service de pneumologie, CRCM - Centre de Transplantation Pulmonaire, Suresnes, France展开收起
127
天
Is the gut a reservoir of non-tuberculous mycobacteria in people with cystic fibrosis?
作者
Jennifer Hudson; Nicole Taylor; Michael J. Coffey; B.L.D. Uthpala Pushpakumara; Bernadette Prentice; Adam Jaffe; Simone Visser; Sheila Sivam; Andrew S. Day; Mark Oliver; Sarath Ranganathan; Hiran Selvadurai; Claire Wainwright; Chee Y. Ooi; Josie van Dorst展开收起
作者单位
School of Clinical Medicine, Discipline of Paediatrics and Child Health, The University of New South Wales, Sydney, Australia; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, Australia; Department of Gastroenterology, Sydney Children’s Hospital, Randwick, Australia; Department of Respiratory Medicine, Sydney Children’s Hospital, Randwick, Australia; Sydney Medical School, University of Sydney, Camperdown, Australia; Department of Paediatrics and Child Health, University of Otago Christchurch, Christchurch, New Zealand; Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Melbourne, Australia; Respiratory Diseases, Murdoch Research Children's Institute, Royal Children's Hospital, Parkville, Victoria, Australia; Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia; Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Centre for Child Health Research, University of Queensland, South Brisbane, QLD, Australia; Department of Respiratory and Sleep Medicine, Queensland Children's Hospital Brisbane, South Brisbane, QLD, Australia展开收起
108
天
Impact of ETI therapy on bone health, body composition and cardiopulmonary fitness in children with CF
作者
A Holden; P Burns; A Devenny; L Thomson; R Langley; S Shepherd; A Mason展开收起
作者单位
University of Glasgow, Glasgow, UK; Department of Sleep and Respiratory Physiology, Royal Hospital for Children, Glasgow, UK; Department of Paediatric Respiratory Medicine, Royal Hospital for Children, Glasgow, UK; Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK展开收起
136
天
Economic evaluation of CFTR modulator therapies in cystic fibrosis: a cost-benefit and cost-effectiveness perspective from the REMEDIA European commission project
作者
Ariel Beresniak; A Daruich; Matthieu Patrice Robert; L Niddam; A Juusti-Hawkes; D Bremond-Gignac展开收起
作者单位
Data Mining International, Geneva, Switzerland; INSERM UMRS 1138, Team 17, Paris, France; OPHTARA Rare Diseases Center, University Hospital Necker Enfants malades, AP-HP, Paris, France; Wellspring, Budapest, Hungary展开收起
161
天
Lung mucus burden and treatment response assessed by MRI in the post-modulator era
作者
Alexander M Matheson; Evan Prather; Matthew M Willmering; Jaime Mata; Giles Santyr; Felix A Ratjen; Elizabeth L Kramer; Zackary I Cleveland; Jason C Woods展开收起
作者单位
Center for Pulmonary Imaging Research, Cincinnati Children's Hospital, Cincinnati, OH, United States; Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, OH, United States; Department of Pediatrics, The University of Cincinnati, Cincinnati, OH, United States; College of Medicine, The University of Cincinnati, Cincinnati, OH, United States; University of Virginia, Virginia, VA, United States; Department of Radiology, The Hospital for Sick Children, Toronto, ON, Canada; Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada展开收起
FAQ
Journal of Cystic Fibrosis审稿要多久?
截至2026-11-19,CrushSCI 收录了 Journal of Cystic Fibrosis 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 40 天(Microbiological outcomes associated with Burkholderia species in people with cystic fibrosis receiving CFTR modulator therapy,2026-02-01 收稿,2026-03-13 录用),最慢一篇用了 225 天;平均 129.1 天,中位数 124 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
